Mar 18,2019

Theranica Raises $35M to Bring Innovative Migraine Device to the USA aMoon leads round B of financing of the Israel-based company

Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases, announced the closing of its round B of financing, of $35 Million, led by aMoon, Israel's largest healthcare VC. All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in the round.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 18,2019

Swedish respiratory health startup NuvoAir raises $3M

This week Swedish startup NuvoAir, best known for making respiratory monitors, scored $3 million in new funding. The latest round was led by Inustrifonden, with participation from Investment AB Spiltan. The company made a name for itself with a smartphone spirometer able to conduct lung function assessments in a home environment. Last year the company launched the Air Next system, a small and portable device that connects to users’ smartphones or tablets using Bluetooth LE. The tool was designed for people living with respiratory conditions such as asthma, COPD and cystic fibrosis.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
May 21,2019

Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Medicine Platform

Biofourmis, a fast-growing leader in digital medicine, today announced that it has successfully closed $35 million in Series B financing. The new injection of funding and move to the U.S. will enable Biofourmis to advance its proprietary artificial intelligence (AI)-powered digital medicine platform and pipeline that treats and manages a range of complex chronic conditions.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 19,2019

Vida Health's $30M round includes deals with investors Teladoc Health, Guidewell, Workday

Digital chronic condition management company Vida Health has raised $30 million in a strategic Series C round. Contributors to the round included Florida Blue parent company GuideWell Mutual Holding Corporation, telemedicine giant Teladoc Health and Workday Ventures, the investment arm of enterprise cloud software company Workday, all of which also announced new partnerships or integrations with Vida Health.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jun 26,2019

Omada Health Raises $73 Million to Accelerate Program Expansion

Omada Health today announced a $73 million round of funding led by Wellington Management Company LLP. Wellington Management is an independent investment firm with more than $1 trillion of client assets under management. Omada will use the funding to fuel the continued expansion of its digital care program, including support for those with type 2 diabetes and hypertension, as well as those dealing with anxiety and depression.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Aug 06,2019

Digital IBS therapy maker metaMe Health closes $3.8M seed round

Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers. The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger irritable bowel syndrome (IBS). The startup said that the seed funding will support continued development of Regulora, particularly through the initiation of a large, randomized controlled trial of IBS patients.

FUNDING SEED

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 17,2019

Backed by Optum Ventures, Kaia Health Raises $8M for AI-Driven Digital Therapeutics for Back Pain & COPD

Kaia Health, a digital therapeutics startup that creates accessible, evidence-based treatments for a range of disorders including back pain and COPD, today announced it has raised $8M in funding led by Optum Ventures, part of UnitedHealth Group (UHG). The funding marks the second significant investment for Optum Ventures in the digital therapeutics space this year.

FUNDING FUNDING ROUND

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Sep 17,2019

One Drop Launches Global Commercial Partnership with Bayer and Announces $40M in Series B Financing

One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, today announced $40 million in Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world. Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease, and women’s health. Stefan Oelrich, the President of Bayer Pharmaceuticals, will join One Drop’s Board of Directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 07,2019

Pear Therapeutics rakes in $64M for reSET commercialization, product development

On Friday Boston-based Pear Therapeutics announced a whopping $64 million Series C funding. The latest financing was led by Temasek, with participation from Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative and EDBI.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 08,2019

Digital therapeutics company HealthBeacon closes $12m Series A investment round

Dublin-headquartered digital therapeutics company HealthBeacon has closed a $12m Series A investment round to fuel its push into the US, Canada and UK markets. The company, which develops smart tools to manage medication, made the announcement at the JP Morgan Digital Medicine and Medtech Showcase in San Francisco this week. Its smart sharps bin solution aims to help patients who self-inject medications at home improve adherence to prescription schedules.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING